Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

GENE:

MET (MET proto-oncogene, receptor tyrosine kinase)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related tests:

‹

FoundationOne® CDx (110)

Guardant360® CDx (54)

FoundationOne® Liquid CDx (21)

MSK-IMPACT (21)

Oncomine™ Dx Target Test (11)

TruSeq®Amplicon - Cancer Panel (5)

Oncomine™ Pan-Cancer Cell-Free Assay (4)

TruSight Oncology 500 Assay (3)

Guardant360 TissueNext™ (2)

HTG EdgeSeq Oncology Biomarker Panel (OBP) (2)

Oncomine™ Comprehensive Assay v3M (2)

AmoyDx® Pan Lung Cancer PCR Panel (1)

Archer® FusionPlex® Comprehensive Thyroid & Lung (CTL) Kit (1)

Idylla™ GeneFusion Assay (1)

InVisionFirst®-Lung (1)

AVENIO Tumor Tissue CGP Kit

AVENIO Tumor Tissue Surveillance Kit

AVENIO Tumor Tissue Targeted Kit

AVENIO ctDNA Surveillance Kit

AVENIO ctDNA Targeted Kit

AmoyDx MET Mutation Detection Kit

AmoyDx® Essential NGS Panel

AmoyDx® HANDLE Classic NGS Panel

AmoyDx® Master Panel

AnchorAIM® 10 Gene Test for Individualized Treatment of Lung Cancer

AnchorAIM® 72 gene detection for individualized treatment of solid tumors

Archer® FusionPlex® Lung Kit

Archer® VariantPlex® Comprehensive Thyroid and Lung (CTL) kit

Archer® VariantPlex® Solid Tumor Kit

Archer™ FusionPlex™ Core Solid Tumor Panel

Archer™ VARIANTPlex™ Complete Solid Tumor panel

Archer™ VARIANTPlex™ Pan Solid Tumor panel

BROCA Cancer Risk Panel

Blueprint Genetics Comprehensive Hereditary Cancer Panel

CancerNext-Expanded®

CustomNext-Cancer®

Droplex c-Met Exon14 Skipping Test

FusionPlex® Dx

FusionPlex® Pan Solid Tumor v2 panel

GALEAS™ Hereditary Plus

Geneseeq’s NGS Liquid Biopsy Kit

GenomicsNext™ Liquid Biopsy

HDPCR NSCLC RUO Assay

Ion AmpliSeq Colon and Lung Cancer Research Panel v2

Labcorp® Plasma Complete™

Labcorp® Plasma Focus™

Liquid Trace™ Solid Tumor

LiquidHALLMARK®

Lung Cancer 8-Gene Kit

LungCure™ CDx

NGS Targeted Hotspot Panel

NeXT Dx™ Test

NeoLAB® Solid Tumor Liquid Biopsy

NeoTYPE® Lung Tumor Profile

Northstar Select™

NovoFocus™ CRC 2.0

NovoFocus™ NSCLC 2.0 Test

OncoGuide™ NCC Oncopanel System

OncoKey™ SL 60 Plus Assay

OncoPanel™ Assay

OncoScreen™ Focus CDx Tissue Kit

Oncomine Dx Express Test

Oncomine Focus Assay

Oncomine Lung Cell-Free Total Nucleic Acid Research Assay

Oncomine Precision Assay

Oncomine™ Comprehensive Assay Plus

Oncomine™ Lung cfDNA Assay

Oncotype MAP™ Pan-Cancer Tissue Test

OptiSeq™ Colorectal Cancer Panel

OptiSeq™ Lung Cancer Panel

OptiSeq™ Pan-Cancer Gene Panel

PGDx elio® plasma focus™ Dx

PGDx elio™ plasma resolve assay

PredicineCARE™

SOPHiA DDM Dx RNAtarget Oncology Solution

SOPHiA DDM™ Solid Tumor Plus Solution

Solid Tumor Profile Plus

StrataNGS™ Test

Target Selector™ NGS Lung Panel

Tempus xF+ Panel

TruSight Oncology Comprehensive

TruSight Tumor 15 Assay

TruSight Tumor 170 Assay

VENTANA® MET (SP44) RxDx Assay

VarMap™ Pan-Cancer NGS Panel

oncoReveal™ Core LBx

oncoReveal™ Essential LBx

oncoReveal™ Fusion LBx Panel

oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel

oncoReveal™ Solid Tumor v2 Panel

FoundationOne® CDx (110)

Guardant360® CDx (54)

FoundationOne® Liquid CDx (21)

MSK-IMPACT (21)

Oncomine™ Dx Target Test (11)

TruSeq®Amplicon - Cancer Panel (5)

Oncomine™ Pan-Cancer Cell-Free Assay (4)

TruSight Oncology 500 Assay (3)

Guardant360 TissueNext™ (2)

HTG EdgeSeq Oncology Biomarker Panel (OBP) (2)

Oncomine™ Comprehensive Assay v3M (2)

AmoyDx® Pan Lung Cancer PCR Panel (1)

Archer® FusionPlex® Comprehensive Thyroid & Lung (CTL) Kit (1)

Idylla™ GeneFusion Assay (1)

InVisionFirst®-Lung (1)

AVENIO Tumor Tissue CGP Kit

AVENIO Tumor Tissue Surveillance Kit

AVENIO Tumor Tissue Targeted Kit

AVENIO ctDNA Surveillance Kit

AVENIO ctDNA Targeted Kit

AmoyDx MET Mutation Detection Kit

AmoyDx® Essential NGS Panel

AmoyDx® HANDLE Classic NGS Panel

AmoyDx® Master Panel

AnchorAIM® 10 Gene Test for Individualized Treatment of Lung Cancer

AnchorAIM® 72 gene detection for individualized treatment of solid tumors

Archer® FusionPlex® Lung Kit

Archer® VariantPlex® Comprehensive Thyroid and Lung (CTL) kit

Archer® VariantPlex® Solid Tumor Kit

Archer™ FusionPlex™ Core Solid Tumor Panel

Archer™ VARIANTPlex™ Complete Solid Tumor panel

Archer™ VARIANTPlex™ Pan Solid Tumor panel

BROCA Cancer Risk Panel

Blueprint Genetics Comprehensive Hereditary Cancer Panel

CancerNext-Expanded®

CustomNext-Cancer®

Droplex c-Met Exon14 Skipping Test

FusionPlex® Dx

FusionPlex® Pan Solid Tumor v2 panel

GALEAS™ Hereditary Plus

Geneseeq’s NGS Liquid Biopsy Kit

GenomicsNext™ Liquid Biopsy

HDPCR NSCLC RUO Assay

Ion AmpliSeq Colon and Lung Cancer Research Panel v2

Labcorp® Plasma Complete™

Labcorp® Plasma Focus™

Liquid Trace™ Solid Tumor

LiquidHALLMARK®

Lung Cancer 8-Gene Kit

LungCure™ CDx

NGS Targeted Hotspot Panel

NeXT Dx™ Test

NeoLAB® Solid Tumor Liquid Biopsy

NeoTYPE® Lung Tumor Profile

Northstar Select™

NovoFocus™ CRC 2.0

NovoFocus™ NSCLC 2.0 Test

OncoGuide™ NCC Oncopanel System

OncoKey™ SL 60 Plus Assay

OncoPanel™ Assay

OncoScreen™ Focus CDx Tissue Kit

Oncomine Dx Express Test

Oncomine Focus Assay

Oncomine Lung Cell-Free Total Nucleic Acid Research Assay

Oncomine Precision Assay

Oncomine™ Comprehensive Assay Plus

Oncomine™ Lung cfDNA Assay

Oncotype MAP™ Pan-Cancer Tissue Test

OptiSeq™ Colorectal Cancer Panel

OptiSeq™ Lung Cancer Panel

OptiSeq™ Pan-Cancer Gene Panel

PGDx elio® plasma focus™ Dx

PGDx elio™ plasma resolve assay

PredicineCARE™

SOPHiA DDM Dx RNAtarget Oncology Solution

SOPHiA DDM™ Solid Tumor Plus Solution

Solid Tumor Profile Plus

StrataNGS™ Test

Target Selector™ NGS Lung Panel

Tempus xF+ Panel

TruSight Oncology Comprehensive

TruSight Tumor 15 Assay

TruSight Tumor 170 Assay

VENTANA® MET (SP44) RxDx Assay

VarMap™ Pan-Cancer NGS Panel

oncoReveal™ Core LBx

oncoReveal™ Essential LBx

oncoReveal™ Fusion LBx Panel

oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel

oncoReveal™ Solid Tumor v2 Panel

›

MET exon 14 mutation	Non Small Cell Lung Cancer	MET exon 14 mutation	Non Small Cell Lung Cancer	tepotinib Sensitive: A1 - Approval tepotinib Sensitive : A1	tepotinib Sensitive: A1 - Approval tepotinib Sensitive : A1
MET exon 14 mutation	Non Small Cell Lung Cancer	MET exon 14 mutation	Non Small Cell Lung Cancer	capmatinib Sensitive: A1 - Approval capmatinib Sensitive : A1	capmatinib Sensitive: A1 - Approval capmatinib Sensitive : A1
MET exon 14 mutation	Non Small Cell Lung Cancer	MET exon 14 mutation	Non Small Cell Lung Cancer	savolitinib Sensitive: A1 - Approval savolitinib Sensitive : A1	savolitinib Sensitive: A1 - Approval savolitinib Sensitive : A1
MET exon 14 mutation	Non Small Cell Lung Cancer	MET exon 14 mutation	Non Small Cell Lung Cancer	APL-101 Sensitive: A1 - Approval APL-101 Sensitive : A1	APL-101 Sensitive: A1 - Approval APL-101 Sensitive : A1
MET exon 14 mutation	Non Small Cell Lung Cancer	MET exon 14 mutation	Non Small Cell Lung Cancer	gumarontinib Sensitive: A1 - Approval gumarontinib Sensitive : A1	gumarontinib Sensitive: A1 - Approval gumarontinib Sensitive : A1
MET amplification	Non Small Cell Lung Cancer	MET amplification	Non Small Cell Lung Cancer	crizotinib Sensitive: A2 - Guideline crizotinib Sensitive : A2	crizotinib Sensitive: A2 - Guideline crizotinib Sensitive : A2
MET exon 14 mutation	Non Small Cell Lung Cancer	MET exon 14 mutation	Non Small Cell Lung Cancer	crizotinib Sensitive: A2 - Guideline crizotinib Sensitive : A2	crizotinib Sensitive: A2 - Guideline crizotinib Sensitive : A2
MET amplification	Non Small Cell Lung Cancer	MET amplification	Non Small Cell Lung Cancer	tepotinib Sensitive: A2 - Guideline tepotinib Sensitive : A2	tepotinib Sensitive: A2 - Guideline tepotinib Sensitive : A2
MET amplification	Renal Cell Carcinoma	MET amplification	Renal Cell Carcinoma	savolitinib Sensitive: A2 - Guideline savolitinib Sensitive : A2	savolitinib Sensitive: A2 - Guideline savolitinib Sensitive : A2
MET expression	Gastroesophageal Junction Adenocarcinoma	MET expression	Gastroesophageal Junction Adenocarcinoma	AMG 102 Resistant: B - Late Trials AMG 102 Resistant : B	AMG 102 Resistant: B - Late Trials AMG 102 Resistant : B
MET amplification	Gastroesophageal Junction Adenocarcinoma	MET amplification	Gastroesophageal Junction Adenocarcinoma	AMG 102 Resistant: B - Late Trials AMG 102 Resistant : B	AMG 102 Resistant: B - Late Trials AMG 102 Resistant : B
MET expression	Gastric Adenocarcinoma	MET expression	Gastric Adenocarcinoma	AMG 102 Resistant: B - Late Trials AMG 102 Resistant : B	AMG 102 Resistant: B - Late Trials AMG 102 Resistant : B